These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 1926878)
21. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587 [TBL] [Abstract][Full Text] [Related]
22. [Use of tamoxifen in patients with disseminated and local breast neoplasms]. Semiglazov VF; Gershanovich ML; Kondrat'ev VB; Moiseenko VM Vopr Onkol; 1984; 30(9):39-43. PubMed ID: 6495691 [TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis. Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590 [TBL] [Abstract][Full Text] [Related]
24. [Treatment of advanced breast cancer with tamoxifen (author's transl)]. Alonso Muñóz A; Pérez Manga G; Moreno Esteban B; Muñóz Gómez S; Madrigal Alonso PL; Pérez Modrego S Med Clin (Barc); 1980 Jul; 75(3):93-7. PubMed ID: 7401744 [TBL] [Abstract][Full Text] [Related]
25. [Modulation of indications of adjuvant hormone therapy with tamoxifen in T1T2/N0N1 breast cancers. Preliminary results of a multicenter study with 695 cases]. Bolla M; Mousseau M; Winckel P; Marron-Charrière J; Colonna M; Pasquier D; Chédin M; Panh MH; Seigneurin D; Salvat J Bull Cancer; 1994 Dec; 81(12):1085-90. PubMed ID: 7742597 [TBL] [Abstract][Full Text] [Related]
26. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679 [TBL] [Abstract][Full Text] [Related]
27. Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. Smith IE; Harris AL; Morgan M; Gazet JC; McKinna JA Cancer Res; 1982 Aug; 42(8 Suppl):3430s-3433s. PubMed ID: 7044525 [TBL] [Abstract][Full Text] [Related]
28. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience. Buzdar AU; Powell KC; Blumenschein GR Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209 [TBL] [Abstract][Full Text] [Related]
29. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148 [TBL] [Abstract][Full Text] [Related]
30. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526 [TBL] [Abstract][Full Text] [Related]
31. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52. Ingle JN; Suman VJ; Mailliard JA; Kugler JW; Krook JE; Michalak JC; Pisansky TM; Wold LE; Donohue JH; Goetz MP; Perez EA Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529 [TBL] [Abstract][Full Text] [Related]
32. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. Mariotto AB; Feuer EJ; Harlan LC; Abrams J J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888 [TBL] [Abstract][Full Text] [Related]
34. Tamoxifen retinopathy. Kaiser-Kupfer MI; Lippman ME Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693 [TBL] [Abstract][Full Text] [Related]
35. Thermal gradient and response to estrogens or antiestrogens in advanced breast cancer. Di Pietro S; Rovini D; Luini A; Muscolino G; Viganotti G Tumori; 1980 Aug; 66(4):459-65. PubMed ID: 7414710 [TBL] [Abstract][Full Text] [Related]
37. Tamoxifen in disseminated breast cancer. Ferrazzi E; Cartei G; De Besi P; Fornasiero A; Palù G; Paccagnella A; Sperandio P; Fosser V; Grigoletto E; Fiorentino M Tumori; 1977; 63(5):463-8. PubMed ID: 601876 [TBL] [Abstract][Full Text] [Related]
38. Tamoxifen treatment of advanced breast carcinoma. Roesdahl K Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):203-8. PubMed ID: 93402 [TBL] [Abstract][Full Text] [Related]
39. Poor response of breast cancer to tamoxifen. McDonald PJ; Carpenter R; Royle GT; Taylor I Postgrad Med J; 1990 Dec; 66(782):1029-31. PubMed ID: 2084647 [TBL] [Abstract][Full Text] [Related]